Table: Fuso Pharmaceutical -2020/21 parent results

Fuso Pharmaceutical Industries

12/05/2021 05:40

May 12 (Reuters)- 
          Fuso Pharmaceutical Industries Ltd 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to       NEXT   
              Mar 31, 2021    Mar 31, 2020   Mar 31, 2022     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales           49.25           46.90          48.50        24.50    
               (+5.0 pct)      (+1.8 pct)     (-1.5 pct)    (-1.7 pct) 
  Operating        2.35            1.01           1.20       600 mln   
              (+132.6 pct)     (-19.9 pct)    (-49.0 pct)  (-64.8 pct) 
  Recurring        2.23            1.07           1.10       600 mln   
              (+108.8 pct)     (-16.6 pct)    (-50.6 pct)  (-64.5 pct) 
  Net              1.61          707 mln        700 mln      350 mln   
              (+127.3 pct)     (-21.0 pct)    (-56.4 pct)  (-72.9 pct) 
  EPS          183.18 yen       80.59 yen      79.78 yen    39.89 yen  
  Ann Div       60.00 yen       60.00 yen      60.00 yen               
  -Q2 Div       30.00 yen       30.00 yen      30.00 yen               
  -Q4 Div       30.00 yen       30.00 yen      30.00 yen               
  
  NOTE - Fuso Pharmaceutical Industries Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4538.T